Our disclosure log publishes responses that we have provided under the Freedom of Information Act (FOIA). They are displayed by subject and in the order in which they were received. If you would like to make a request under the FOIA please check here first to see if the information you need has already been released.
If you have any comments or queries about the log please contact uclh.
| Title | Description | FOI Category | Date Received |
|---|---|---|---|
| Ref no FOI.2024.0465 Response | |||
| Ref no FOI.2024.0465 Response | |||
| Ref no FOI.2024.0612 Response | |||
| Ref no FOI.2019.547 Response | |||
| Ref no-FOI.2018.654 Response Info Supplied | |||
| Ref no FOI.2019.209 239 and 252 254 and 263 286 Response | |||
| Ref no FOI.2020.0106 Response | FOI/2020/0106 - Bereavement service | Bereavement services | 04/02/2020 |
| FOI2017257Response | FOI2017257 Public health funerals | Bereavement services | 07/04/2017 |
| Ref no FOI.2020.0177 Response | FOI/2020/0177 - Bereavement services | Bereavement services | 05/03/2020 |
| Ref no FOI.2024.0523 Response | FOI/2024/05523 - Dabrafenib + Trametinib cancer treatment for metastatic and adjuvant melanoma/ lung/ colorectal cancer | Cancer | 12/06/2024 |
| Ref no FOI.2021.0322 Response | FOI/2021/0322 - Incidence and treatment of breast cancer | Cancer | 01/06/2021 |
| Ref no FOI.2023.0141 Response | FOI/2023/0141 - Longest cancer waits | Cancer | 20/02/2023 |
| Ref no FOI.2024.0527 Response | FOI/2024/0527 - Treatment for renal cell carcinoma | Cancer | 13/06/2024 |
| Ref no FOI.2023.0522 Response | FOI/2023/0522 - Urology cancer pathway | Cancer | 26/07/2023 |
| Ref no FOI.2019.450 Response | FOI/2019/450 Patient diagnosis of breast cancer | Cancer | 18/06/2019 |
| Ref no FOI.2024.0356 Response | FOI/2024/0356 - Treatment with Durvalumab and Nivolumab for biliary tract/ non-small cell lung cancer | Cancer | 11/04/2024 |
| Ref no FOI.2024.0357 Response | FOI/2024/0357 - Multiple myeloma treatments | Cancer | 11/04/2024 |
| Ref no FOI.2019.403 Response | FOI/2019/403 Proton Beam Therapy (PBT) | Cancer | 30/05/2019 |
| Ref no FOI.2020.0514 Response | FOI/2020/0514 - Prostate cancer diagnosis | Cancer | 08/10/2020 |
| Ref no FOI.2021.0436 Response | FOI/2021/0436 - Oesophageal and gastric cancer | Cancer | 16/07/2021 |
| Ref no FOI.2024.0371 Response | FOI/2024/0371 - Acute myeloid leukaemia treatment | Cancer | 16/04/2024 |
| Ref no FOI.2023.0954 Response | FOI/2023/0954 - Treatment of melanoma/ Renal cell carcinoma/ Oesophageal cancer | Cancer | 15/12/2023 |
| Ref no FOI.2022.0456 Response | FOI/2022/0456 - Treatment of renal cell carcinoma | Cancer | 01/08/2022 |
| Ref no FOI.2019.50 Response | FOI/2019/50 Guidelines post colonoscopy | Cancer | 22/01/2019 |
| Ref no FOI.2022.0781 Response | FOI/2022/0781 - Protocols for diagnosis and treatment of non-small cell lung cancer | Cancer | 19/12/2022 |
| Ref no FOI.2023.0870 Response | FOI/2023/0870 - Cancer treatments cancelled or rescheduled | Cancer | 15/11/2023 |
| Ref no FOI.2024.0582 Response | FOI/2024/0582 - SACT (systemic anti-cancer therapy) treatments for endometrial cancer | Cancer | 08/07/2024 |
| Ref no FOI.2022.0705 Response | FOI/2022/0705 - Head/ neck and urothelial cancer treatment | Cancer | 11/11/2022 |
| Ref no FOI.2023.0500 Response | FOI/2023/0500 - Treatment of urothelial and colorectal cancer | Cancer | 12/07/2023 |
| Ref no FOI.2022.0506 Response | FOI/2022/0506 - Node positive breast cancer patients undergoing Oncotype testing | Cancer | 18/08/2022 |
| Ref no FOI.2024.0491 Response | FOI/2024/0491 - Breast cancer treatment | Cancer | 03/06/2024 |
| Ref no FOI.2023.0491 Response | FOI/2023/0491 - Treatment for oesophageal and gastric cancer | Cancer | 10/07/2023 |
| Ref no FOI.2022.0091 Response | FOI/2022/0091 - Pancreatic cancer | Cancer | 16/02/2022 |
| Ref no FOI.2023.0675 Response | FOI/2023/0675 - Number of cancer treatments at each stage | Cancer | 11/09/2023 |
| Ref no FOI.2023.0499 Response | FOI/2023/0499 - Treatments for non-small cell lung cancer | Cancer | 12/07/2023 |
| Ref no FOI.2021.0055 Response | FOI/2021/0055 - Support for family members of patients with cancer | Cancer | 01/02/2021 |
| Ref no FOI.2020.0014 Response | FOI/2020/0014 - Services for pelvic radiation disease | Cancer | 06/01/2020 |
| Ref no FOI.2021.0220 Response | FOI/2021/0220 - Cancer referrals | Cancer | 21/04/2021 |
| Ref no FOI.2023.0808 Response | FOI/2023/0808 - Full blood count tests for chemotherapy cancer treatment | Cancer | 26/10/2023 |
| Ref no FOI.2019.535 Response | FOI/2019/535 NICE Guidance DG34 Tumour Profiling Test - breast cancer | Cancer | 18/07/2019 |
| Ref no FOI.2023.0810 Response | FOI/2023/0810 - Inflammatory Bowel Disease colorectal cancer colonoscopy surveillance endoscopy | Cancer | 27/10/2023 |
| Ref no FOI.2020.0007 Response | FOI/2020/0007 - Radical radiotherapy to the breast or chestwall | Cancer | 05/01/2020 |
| Ref no FOI.2023.0811 Response | FOI/2023/0811 - HIFU partial ablation/ prostate cancer detection | Cancer | 30/10/2023 |
| Ref no FOI.2021.0499 Response | FOI/2021/0499 - Cancer pathway started treatment | Cancer | 17/08/2021 |
| Ref no FOI.2024.0662 Response | FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma | Cancer | 06/08/2024 |
| Ref no FOI.2022.0119 Response | FOI/2022/0119 - Chemotherapy for patients with osteosarcoma | Cancer | 28/02/2022 |
| Ref no FOI.2023.0508 Response | FOI/2023/0508 - Lynch syndrome clinical pathway | Cancer | 14/07/2023 |
| Ref no FOI.2024.0659 Response | FOI/2024/0659 - Treatment of cancers; breast/ prostate/ ovarian and endometrial | Cancer | 06/08/2024 |
| Ref no FOI.2022.0686 Response | FOI/2022/0686 - Breast cancer patients | Cancer | 07/11/2022 |
| Ref no FOI.2024.0520 Response | FOI/2024/0520 - Treatment of melanoma | Cancer | 12/06/2024 |